Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Antoine

Showing results (141-150 of 157) with videos related to

Pageof 16
Sort By:
Hepatology (Baltimore, Md.)|July 31, 2016
A novel high mobility group box 1 neutralizing chimeric antibody attenuates drug-induced liver injury and postinjury inflammation in micePeter Lundbäck, Jonathan D Lea, Agnieszka Sowinska, et al.
Brain : a Journal of Neurology|June 3, 2017
Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsyAlberto Pauletti, Gaetano Terrone, Tawfeeq Shekh-Ahmad, et al.
Journal of Hepatology|May 5, 2015
Extracorporeal liver assist device to exchange albumin and remove endotoxin in acute liver failure: Results of a pivotal pre-clinical studyKarla C L Lee, Luisa A Baker, Giacomo Stanzani, et al.
JCI Insight|December 21, 2018
Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexesHuan Yang, Haichao Wang, Yaakov A Levine, et al.
Journal of the American Society of Nephrology : JASN|June 7, 2014
Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetesVenkata S Sabbisetti, Sushrut S Waikar, Daniel J Antoine, et al.
JCI Insight|June 14, 2016
Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexesHuan Yang, Haichao Wang, Yaakov A Levine, et al.
JCI Insight|December 21, 2018
Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexesHuan Yang, Haichao Wang, Yaakov A Levine, et al.
Nature|July 18, 2012
Novel role of PKR in inflammasome activation and HMGB1 releaseBen Lu, Takahisa Nakamura, Karen Inouye, et al.
Medicinal Research Reviews|October 24, 2012
The generation, detection, and effects of reactive drug metabolitesAndrew V Stachulski, Thomas A Baillie, B Kevin Park, et al.
Journal of Internal Medicine|July 2, 2013
HMGB1 mediates splenomegaly and expansion of splenic CD11b+ Ly-6C(high) inflammatory monocytes in murine sepsis survivorsS I Valdés-Ferrer, M Rosas-Ballina, P S Olofsson, et al.
Pageof 16

Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
Hepatology (Baltimore, Md.)|July 31, 2016
A novel high mobility group box 1 neutralizing chimeric antibody attenuates drug-induced liver injury and postinjury inflammation in micePeter Lundbäck, Jonathan D Lea, Agnieszka Sowinska, et al.
Brain : a Journal of Neurology|June 3, 2017
Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsyAlberto Pauletti, Gaetano Terrone, Tawfeeq Shekh-Ahmad, et al.
Journal of Hepatology|May 5, 2015
Extracorporeal liver assist device to exchange albumin and remove endotoxin in acute liver failure: Results of a pivotal pre-clinical studyKarla C L Lee, Luisa A Baker, Giacomo Stanzani, et al.
JCI Insight|December 21, 2018
Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexesHuan Yang, Haichao Wang, Yaakov A Levine, et al.
Journal of the American Society of Nephrology : JASN|June 7, 2014
Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetesVenkata S Sabbisetti, Sushrut S Waikar, Daniel J Antoine, et al.
JCI Insight|June 14, 2016
Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexesHuan Yang, Haichao Wang, Yaakov A Levine, et al.
JCI Insight|December 21, 2018
Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexesHuan Yang, Haichao Wang, Yaakov A Levine, et al.
Nature|July 18, 2012
Novel role of PKR in inflammasome activation and HMGB1 releaseBen Lu, Takahisa Nakamura, Karen Inouye, et al.
Medicinal Research Reviews|October 24, 2012
The generation, detection, and effects of reactive drug metabolitesAndrew V Stachulski, Thomas A Baillie, B Kevin Park, et al.
Journal of Internal Medicine|July 2, 2013
HMGB1 mediates splenomegaly and expansion of splenic CD11b+ Ly-6C(high) inflammatory monocytes in murine sepsis survivorsS I Valdés-Ferrer, M Rosas-Ballina, P S Olofsson, et al.
Pageof 16